Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes — Stella

Recruiting

Back to Vulvovaginal Candidiasis trials

Trial locations(1 site)

India

AWINSA, New Delhi, Vasant Vihar

Key details

Sponsor

Scynexis, Inc.

Collaborators

AWINSA

Enrollment target

~100 participants

Started

July 2022

Primary completion

October 2029

Age range

0 Years and older

Sex

Female only

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov